Bluebird Bio and Celgene Partner to Advance bb2121, Potential Multiple Myeloma CAR T-cell Therapy
The investigational therapy bb2121, a possible treatment for…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
ACCoRd Trial to Test Ninlaro Treatment for ASCT-Relapsed Multiple Myeloma
A new Phase 3 clinical trial called ACCoRd is…
AbbVie, IMF Team Up to Study Gene Mutation in Myeloma Outcomes
AbbVie and the International Myeloma Foundation are collaborating…
SELLAS Vaccine More Than Doubles Time to Myeloma Progression, Phase 2 Trial Shows
SELLAS Life Sciences’  Galinpepimut-S vaccine more than doubles…
Medicinal Cannabis Safe and Effective for Pain, Chemo Side Effects, Journal Says
The supervised use of medicinal cannabis is safe and…
Myeloma Patients Refractory to Revlimid May Benefit from Ninlaro, Pomalyst, Dexamethasone Combo
Multiple myeloma patients who failed prior Revlimid (lenalidomide) treatment may…
